LAMBERTENGHI DELILIERS, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 35.507
NA - Nord America 18.238
AS - Asia 10.929
SA - Sud America 764
OC - Oceania 57
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 10
Totale 65.546
Nazione #
US - Stati Uniti d'America 17.735
DE - Germania 11.272
GB - Regno Unito 10.382
CN - Cina 5.291
IT - Italia 3.674
SE - Svezia 3.067
SG - Singapore 2.136
RU - Federazione Russa 1.793
UA - Ucraina 1.678
TR - Turchia 980
KR - Corea 926
FR - Francia 850
IN - India 815
IE - Irlanda 807
EU - Europa 783
NL - Olanda 567
FI - Finlandia 564
CA - Canada 456
CO - Colombia 404
BR - Brasile 297
HK - Hong Kong 216
GR - Grecia 204
PL - Polonia 144
ID - Indonesia 139
DK - Danimarca 131
VN - Vietnam 115
JP - Giappone 105
BE - Belgio 103
ES - Italia 63
UZ - Uzbekistan 52
AU - Australia 47
CZ - Repubblica Ceca 46
CH - Svizzera 38
MX - Messico 28
RO - Romania 28
AT - Austria 25
TH - Thailandia 19
AR - Argentina 17
IR - Iran 15
IL - Israele 14
PT - Portogallo 14
EC - Ecuador 12
PK - Pakistan 12
MA - Marocco 11
TW - Taiwan 11
NZ - Nuova Zelanda 10
PE - Perù 10
BG - Bulgaria 9
EG - Egitto 9
PH - Filippine 9
BD - Bangladesh 8
HU - Ungheria 8
UY - Uruguay 8
ZA - Sudafrica 8
LT - Lituania 7
AE - Emirati Arabi Uniti 6
VE - Venezuela 6
AL - Albania 5
CI - Costa d'Avorio 5
CL - Cile 5
KE - Kenya 5
LB - Libano 5
NO - Norvegia 5
AZ - Azerbaigian 4
CY - Cipro 4
LI - Liechtenstein 4
LU - Lussemburgo 4
MY - Malesia 4
QA - Qatar 4
SA - Arabia Saudita 4
SI - Slovenia 4
AM - Armenia 3
GT - Guatemala 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MN - Mongolia 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BT - Bhutan 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GL - Groenlandia 2
HR - Croazia 2
IQ - Iraq 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MT - Malta 2
NG - Nigeria 2
TJ - Tagikistan 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
Totale 66.311
Città #
Southend 9.359
Frankfurt am Main 7.177
Chandler 1.922
Beijing 1.735
Jacksonville 1.515
Singapore 1.411
Seattle 1.361
Milan 1.079
Princeton 1.001
Ashburn 948
Wilmington 893
Dublin 798
Redmond 661
Boise 593
Mountain View 550
Ann Arbor 545
Nanjing 541
Council Bluffs 530
Serra 490
Dearborn 486
Somerville 484
Sakarya 438
Andover 430
Bogotá 399
Toronto 379
Woodbridge 355
Bengaluru 319
Boardman 314
Fairfield 304
Des Moines 303
Houston 300
Shanghai 270
Santa Clara 262
Berlin 246
Nanchang 200
Jinan 196
Hangzhou 189
Athens 188
Shenyang 180
Saint Petersburg 161
Hong Kong 155
Kiez 136
Eitensheim 126
New York 125
Grafing 122
Warsaw 119
Los Angeles 118
Bitonto 115
Hebei 115
Helsinki 115
Hanover 113
Guangzhou 107
Tianjin 101
Changsha 99
Rome 97
Phoenix 94
Brussels 93
Auburn Hills 88
Nürnberg 87
Pisa 86
Hamburg 80
Roxbury 80
Jiaxing 78
Kunming 77
Fuzhou 76
Zhengzhou 76
Verona 71
Hefei 69
Cambridge 63
Redwood City 63
Turin 59
San Diego 56
Naples 54
Dong Ket 53
Quanzhou 49
Jakarta 47
Payette 46
Ningbo 44
Norwalk 43
San Jose 41
Haikou 40
Kwai Chung 40
Bühl 38
Lanzhou 38
Garden Valley 37
Fremont 36
London 35
Margão 35
Ottawa 35
Tokyo 35
Medford 33
Kent 32
Taizhou 31
Palermo 30
Seoul 30
Wuhan 30
Jerome 29
Scranton 29
Munich 28
Washington 28
Totale 43.617
Nome #
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report 945
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 600
Burnout e oncologia: una ricerca multicentrica 494
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 448
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies 404
Anti-L-NGFR and -CD34 Monoclonal Antibodies Identify Multipotent Mesenchymal Stem Cells in Human Adipose Tissue 368
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant 337
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 332
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 328
Alterazioni quantitative e qualitative dei leucociti 326
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin lymphoma : final results of a multicenter, randomized trial by the Intergruppo Italiano Linfomi 310
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome 273
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 271
A distinctive trascriptional profile characterizes the chromosome 17p loss in B-cell chronic lymphocytic leukemia 268
A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia 266
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study 264
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 261
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome 253
Analysis of CD44 expression in monoclonal gammopathies : correlation between gene expression level and flow cytometry findings 251
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma : an "Intergruppo Italiano Linfomi" randomized trial 250
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate 249
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 245
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 244
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation 244
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 242
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 238
Ineffective hematopoiesis and markers of angiogeneisis in myelodysplastic syndromes 232
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 231
Prognostic implications of the european consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis 229
Bone microenvironment cells reveal a different gene expression profiling in multiple myeloma patients as compared to healthy subjects : potential relationship with the bone status 228
Four year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation 226
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up with unselected stem cells 222
Bone marrow monocytes in histiocytosis X acquire some phenotypic features of Langerhans cells in long term bone marrow cultures 222
Bone microenvironment cells reveals a different gene expression profyling in multiple myeloma patients in relation to the bone status 217
Evolving pattern of microbial susceptibility to antibiotics in a HSCT unit 216
Circulating versus progenitor endothelial cells are abnormal in patients with different types of von willebrand disease and correlate with markers of angiogenesis : a cohort study of 74 cases” 216
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 215
A novel fish-based normalization procedure for whole genome microarrays detecting accurate local copy numbers : application to multiple myeloma 214
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 213
FISH characterization of t(8;12)(q12;p13) observed as the sole karyotypic anomaly in a myelodysplastic syndrome patient 213
Gene expression signature of the apoptotic patway in indolent CLL by low-density array technology 211
Apoptosis taqman low-density array : analysis of programmed cell death patway in CLL 211
Integrative genomic analysis of trisomy 12 abnormality in B-cell chronic lymphocytic leukemia 209
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 205
Integrative genomics based on microarrays analyses reveals a correlation between allelic imbalances and gene expression patterns in multiple myeloma 204
Analisys of bone marrow hematopoietic and mesenchymal precursors in patients with amyotrophic lateral sclerosis 202
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 200
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 199
Utilizzo di un dispositivo nano tecnologico per fish miniaturizzata (microFind) per l’identificazione di lesioni genetiche in campioni con scarsità cellulare : applicazione nel mieloma multiplo 198
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 197
Evalutation of TIE2-expressing monocytes in myeloid disorders 197
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia 197
Bone microenvironment cells show a different pattern of gene expression profiling in relationship with the presence of osteolytic bone lesions in multiple myeloma patients 196
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 196
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 196
Molecular definition of 17P11-P12 amplification in multiple myeloma 195
Front-line chemo-immunotherapy rituximab-FC + rituximab maintenance in patients with untreated adevanced stage non follicular lymphoma (INFL) : preliminary results of a prospective study of the Intergruppo Italiano Linfomi and Roche (ML18324) 195
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 195
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 195
Functional alteration of bone marrow mesenchymal stem cells of Amyotrophic Lateral Sclerosis Patients 194
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological molecular characterization by a genomic integrative analisys 193
Biological and Clinical Relevance of Surrogate Markers of IgVH Mutational Status in B-Cell Chronic Lymphocytic Leukemia 193
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H 192
Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis 192
Conjunctival hemorrhagic events associated with imatinib 191
Evaluation of deoxycholate amphotericin-B toxicity after HSCT 191
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 191
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial 191
A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma : an integrated genomics approach reveals a wide gene dosage effect 190
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 190
Central nervous system disease in multiple myeloma patients receiving bortezomid to treat post transplant relapse 189
Low-dose subcutaneous alemtuzumab therapy for patients with refractory chronic lymphoblastic leukaemia (B-CLL) 188
Markers of angiogenesis in von willbrand disease 187
Angiogenesis in myelodysplastic syndromes 187
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome 186
Biological and molecular characterization by integrative genomics approach of CMA-03/06, a newly established interleukin-6 independent variant of the CMA-03 human myeloma cell line 186
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR 186
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 186
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia 185
Metalloproteinase alterations in the bone marrow of ALS patients 185
Biological and clinical relevance of quantitative global methylation in repetitive DNA sequences in B-cell chronic lymphocytic leukemia 185
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 185
Reduced-intensity conditioned allogeneic transplantation for advanced mycosis fungoides and Sezary syndrome 184
Evolution of empirical antifungal therapy in a bone marrow transplantation unit 184
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 183
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys 183
Transcriptional features of 1Q in multiple myeloma 182
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 182
Global SNP-based mapping of B-cell chronic lymphocytic leukemia reveals the role of 2p gain in predicting clinical outcome 182
Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders 182
Patterns of global DNA methylation identify early stage (Binet A) CLL patients with higher risk of disease progression 182
Amyotrophic Lateral Sclerosis Bone Marrow Characterization 181
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma 181
Repetitive DNA methylation in multiple myeloma 181
Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines 180
The cytofluorimetric/FISH diagnostic approach define a B-cell variant-CLL with peculiar clinico-biologic features 180
Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia 180
Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases 180
Circulating versus progenitor endothelial cells are abnormal in patients with different types of Von Willebrand disease and correlate with markers of angiogenesis : a cohort study of 74 cases 179
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups 179
Totale 23.211
Categoria #
all - tutte 158.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.582 0 0 0 0 0 0 0 0 0 991 458 133
2020/20217.994 439 638 744 122 587 375 571 263 1.048 358 2.356 493
2021/20224.588 506 109 217 139 241 267 572 224 680 410 250 973
2022/20236.479 878 645 597 650 888 1.318 125 380 591 66 230 111
2023/20248.469 116 310 175 309 1.026 586 1.026 1.076 451 984 1.147 1.263
2024/20257.105 1.132 1.336 843 1.344 645 281 160 940 423 1 0 0
Totale 69.213